Clinical Research Directory
Browse clinical research sites, groups, and studies.
Methamphetamine, PrEP, and Intersectional Stigma Study
Sponsor: Arizona State University
Summary
The goal of this clinical trail is to test the developed eMPrISe study in HIV-negative, adult, Latino men who have sex with men (MSM) who use non-injection substances. The main questions it aims to answer are: * Can participation in the developed eMPrISe study reduce methamphetamine ('meth') use risk? * Can participation in the developed eMPrISe study improve preexposure prophylaxis (PrEP) cascade progression? Participants will participate in 12 weekly modules that: (1) build critical thinking skills, (2) identify and discuss the link between oppression and harmful behaviors, (3) take action, (4) voice and validate feelings and experiences, and (5) share knowledge and resources.
Official title: Addressing Intersectional Stigma Through Coping, Resistance, and Resilience to Improve Methamphetamine Use and Factors Influencing PrEP Uptake Among Latino MSM: a Step Towards Ending HIV by 2030
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-04-15
Completion Date
2027-08-31
Last Updated
2026-02-19
Healthy Volunteers
No
Conditions
Interventions
Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study
Group behavioral intervention with 12 weekly sessions lasting 2 hours focusing on coping, resistance, and resilience.